Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston blog main
boston top stories
eli lilly
7
×
investing
7
×
life sciences
national blog main
san francisco blog main
deals
fda
indiana blog main
national top stories
new york blog main
raleigh-durham blog main
san diego blog main
san francisco top stories
seattle blog main
startups
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
clinical trials
detroit blog main
detroit top stories
indiana top stories
national
new york top stories
pfizer
raleigh-durham top stories
san diego top stories
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
alzheimer's disease
biogen
bristol-myers squibb
What
bio
roundup
drug
alzheimer’s
companies
fda
growing
pharmaceutical
prices
typically
alliance
annual
approval
approved
assessed
attention
bails
beta
bionics
biotech
blood
blueprint
brand
bridgebio
bristol
buy
calls
cancer
candidate
capital
car
changing
closed
color
communities
conference
crispr
currently
days
develop
Language
unset
Current search:
biotech
×
" eli lilly "
×
investing
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
